Anesthesia for Oncological Surgery

• Autore: Huang Jeffrey
• Pubblicazione: Cham : , : Springer International Publishing AG, , 2024; ©2023
• Edizione: 1st ed.
• Descrizione fisica: 1 online resource (459 pages)
• Altri autori: HuangJiapeng LiuHenry
• Nota di contenuto: Intro -- Foreword -- Preface -- Acknowledgments -- Contents -- Part I: Basic Science of Oncology -- Oncogenesis, What Is New? -- 1 Oncogenesis and Personalized Cancer Treatment -- 2 The Increasing Role of Immunotherapy -- 3 The Importance of Tissue Adequacy in Biomarker/Ancillary Studies Testing -- 3.1 Sequencing -- 3.2 Fluorescent In-Situ Hybridization (FISH) -- 3.3 RNA Gene Expression -- 3.4 Liquid Biopsies -- 4 The Environment, Chemicals, and Cancer -- 5 Microbial Oncogenesis -- References -- Epidemiology of Cancer -- 1 Introduction -- 2 Cancer Incidence and Trend -- 3 Lifetime Risk for Cancers -- 4 Survival Rates for Cancers -- 5 Cancer Mortality and Trend -- 6 Risk Factors for Cancers -- 7 Summary -- References -- Immunemodulation and Cancer -- 1 Introduction -- 2 Tumor Immunity -- 2.1 Tumor Immunity Require CD8+ T Cell Activation -- 2.2 T Cell Activation Require Antigen Presenting Cell -- 3 Antigen Presenting Cells and Cancer -- 3.1 Basic Biology of Dendritic Cells -- 3.2 DC Plays Pivotal Roles in Tumor Immunity -- 3.3 Cross Talk of DC with T Cells and NK Cells -- 4 Regulation DC by TLR Receptors -- 4.1 Basic Biology of Toll-like Receptors (TLRs) -- 4.2 TLRs Play a Pivotal Role in Bringing Innate and Adaptive Immunity -- 4.3 Antitumor Effect of TLR3 -- 4.4 Antitumor Effect of TLR7and TLR8 -- 4.5 Antitumor Effect of TLR9 -- 5 Activation of T Cell Mediated Tumor Immunity by Immune Check Point Inhibition -- 5.1 T Cell Mediated Tumor Immunity Is Regulated by Balance of Stimulatory and Inhibitory Receptors (Immune Checkpoints) -- 5.2 Programmed Cell Death Protein 1 and Programmed Cell Death Protein Ligand 1 (PD-1/PDL1) -- 5.3 CTLA-4 -- 5.4 TIM-3 -- 5.5 LAG-3 -- 6 The Tumor Microenvironment -- 6.1 Regulatory T Cells in the TME. ; 6.2 The Infiltration of Tumor Associated Macrophages and Myeloid-Derived Suppressor Cells in the TME -- 7 Summary -- References -- Cancer Targeted Molecular Therapy -- 1 Introduction -- 2 General Strategies for Identifying Cancer Molecular Targets -- 2.1 Conventional Strategies to Identify Specific Tumor Biomarkers -- 2.2 Next-Generation Sequencing (NGS) -- 3 Molecular Targets Associated with Cancer -- 3.1 Targeting ALK Pathway -- 3.2 Targeting BCL-2 Pathways -- 3.3 Targeting BRAF Pathways -- References -- CAR T-Cell Therapy -- 1 Introduction -- 2 FDA-Approved CAR T-Cell Therapies (Accurate as to the Time of Writing) -- 3 Anti-CD19 CAR T-Cells -- 4 Anti-BCMA CAR T-Cells -- 5 Pre-CAR T Cell Therapy Evaluation and Preparation -- 6 Therapy Process -- 7 Toxicities of CAR T-Cell Therapy -- 8 Common Operative Procedures -- 9 Preoperative Assessment -- 10 Anesthetic Management -- 11 Conclusion -- References -- Part II: Perioperative Oncology -- The Surgeon: Anesthesia Professional Relationship -- 1 Introduction -- 2 Operating Team: Anesthesia Team Dynamics -- 3 Surgeon: Anesthesia Professional Familiarity -- 4 Surgeon: Anesthesia Teams -- 5 Special Responsibilities for the Anesthesia Team: A Surgeons' Perspective -- 6 Operation Conduct -- 7 The Operative Team: Anesthesia Team Relationship with Operating Team -- 8 Conclusions -- Further Reading -- Anesthetic Technique and Cancer Recurrence -- 1 Introduction -- 2 Pathogenesis of Cancer Recurrence After Surgery -- 3 Immune Suppression After Surgery -- 4 Anesthetic Techniques and Impacts on Cancer Recurrence -- 4.1 Volatile Anesthetics -- 4.2 Total Intravenous Anesthetics (TIVA) -- 4.3 Total Intravenous Anesthetics (TIVA) Vs. Volatile Agents -- 4.4 Regional/Neuraxial Anesthetics -- 4.4.1 Local Anesthetics and Opioids -- 4.4.2 Regional Anesthesia. ; 4.4.3 Neuraxial Anesthetics -- References -- Prehabilitation -- 1 Introduction -- 2 Prehabilitation -- 3 Nutritional Optimization -- 4 Physical Fitness -- 4.1 Functionality -- 4.2 Physical Deconditioning -- 4.3 Treatment -- 4.4 Precautions to Exercise -- 5 Exercise Training -- 5.1 Mind Body Connection -- 6 Summary -- References -- Preoperative Evaluation and Preparations for Oncological Surgery -- 1 Introduction -- 2 Timing of the Preoperative Evaluation for Oncologic Surgery -- 2.1 Review of Medical History -- 2.2 Review of Oncologic History -- 3 Past Surgical History -- 4 Cardiac Evaluation and Estimation of Cardiac Risk -- 5 Pulmonary Evaluation -- 6 Endocrine Considerations -- 7 Pain Management -- 8 Frailty -- 8.1 Nutrition Assessment -- 9 Physical Exam -- 10 Summary -- References -- Perioperative Surgical Home, Enhanced Recovery After Surgery, and High-Risk Committee -- 1 Introduction -- 2 PSH Core Principles -- 2.1 Elements of the Perioperative Surgical Home -- 2.2 Adoption the PSH Model -- 2.3 The PSH Model for Cancer Patients -- 2.4 Enhanced Recovery After Surgery: Background -- 2.5 ERAS, Postoperative Outcomes and Cancer Outcome Studies -- 3 Peri-operative High-Risk Multidisciplinary Conference -- 4 Summary -- References -- Blood Management for Oncological Surgery -- 1 Introduction -- 2 Indications for Blood Transfusion in the Cancer Patient -- 3 Perioperative Measures to Reduce Blood Transfusion -- 4 Massive Transfusion Protocol -- 5 Transfusion-Related Complications -- 6 Transfusion and Cancer Outcomes -- 7 Conclusions -- References -- Acute Pain Service for Oncological Surgery -- 1 Acute Pain in Oncological Surgery -- 2 General Recommendations for Acute Pain Management in Oncological Surgeries -- 3 Special Considerations for Acute Postoperative Pain Management in Oncological Patients. ; 4 Acute Pain Management in Oncological Neurosurgery -- 4.1 Craniotomy -- 4.2 Spine Surgery -- 5 Acute Pain Management in Head and Neck Oncological Surgery -- 6 Acute Pain Management in Thoracic Oncological Surgery -- 7 Acute Pain Management in Abdominal, Gynecologic, and Urologic Oncological Surgery -- 7.1 Minimally Invasive Techniques (Laparoscopic/Robotic) -- 7.2 Open Abdominal Procedures -- 8 Acute Pain Management in Breast and Orthopedic Oncological Surgery -- 8.1 Breast -- 8.2 Orthopedic -- 8.3 Plastics: Free Flap -- 9 Acute Pain Management in Pediatric Oncological Surgery -- 9.1 Special Considerations -- 9.2 Regional Techniques -- 9.3 Summary -- 10 Postoperative Acute Pain Medical Management -- 10.1 Non-opioid Medications -- 10.2 Opioid Medications -- 11 Regional Analgesia Techniques for Various Types of Surgery -- 11.1 Head and Neck Surgery -- 11.2 Thoracic Surgery -- 11.3 Gastrointestinal, Gynecologic, and Urologic Oncologic Surgery -- 11.4 Breast Surgery -- 11.5 Upper and Lower Extremity Peripheral Nerve Blocks -- 11.6 Complications -- References -- Chronic Pain Clinic in Cancer Center and Oncological Services -- 1 Cancer Pain -- 1.1 Pain Management is Challenging -- 1.1.1 Healthcare Disparities -- 1.1.2 Professional Barriers -- 1.1.3 Patient Barriers -- 1.1.4 Societal Perception of Pain Management -- 1.2 Cancer Pain Management is Even More Challenging -- 2 Chronic Pain Clinics in Cancer Hospitals -- 2.1 Approach to Cancer Pain -- 2.2 Pain Assessment -- 2.3 Pharmacologic Therapy -- 2.3.1 Acetaminophen and Non-steroidal Anti-inflammatories (NSAIDs) -- 2.3.2 Antidepressants -- 2.3.3 Anticonvulsants -- 2.3.4 Opioids -- 2.3.5 Opioid Titration -- 2.3.6 Tolerance -- 2.4 Interventional Pain Modalities -- 2.4.1 Nerve Blocks -- 2.4.2 Nerve Ablations -- 2.4.3 Neuraxial Procedures. ; 2.5 Integrative Medicine -- 2.6 Psychosocial Interventions -- 3 Summary -- References -- Non pharmaceutics Therapy for Oncological Patients -- 1 Introduction -- 2 Physical Interventions -- 3 Psychosocial Interventions -- 4 Integrative Therapies -- 4.1 Herbal Products -- 4.2 Acupuncture -- 4.3 Massage -- 4.4 Yoga -- 4.5 Relaxation and Guided Imagery -- 4.6 Hypnosis -- 4.7 Meditation and Mindfulness -- 4.8 Other Mind Body Practices -- 4.9 Safety -- 5 Summary -- References -- Part III: Oncological Neurosurgery -- Craniotomy for Meningioma -- 1 Facts to Know -- 2 Pathology -- 3 Risk Factors -- 4 Screening -- 5 Diagnosis -- 6 Surgical Treatment -- 6.1 Strategies for Surgical Approaches -- 7 Common Complications -- 8 Medical Treatment -- 8.1 Adjuvant Radiation Treatment -- 8.2 Medical Treatment for Side Effects: [25] -- 9 Anesthesia Considerations -- 9.1 Preoperative Management -- 10 Intraoperative Management -- 11 Postoperative Management -- 12 Potential Concerns -- References -- Craniotomy for Glioma -- 1 Facts to Know -- 2 Pathology -- 3 Risk Factors -- 4 Screening -- 5 Diagnosis -- 6 Surgical Treatment -- 7 Key Surgical Steps -- 8 Dissection -- 9 Closure -- 10 Common Surgical Complications -- 11 Non-Surgical Treatment -- 11.1 Adjuvant Treatment -- 12 Anesthesia Considerations -- 12.1 Preoperative Management -- 12.2 Intraoperative Management -- 12.3 Postoperative Management -- 13 Potential Concerns -- References -- Craniotomy for Brainstem Tumors -- 1 Facts to Know -- 2 Pathology -- 3 Risk Factors -- 4 Screening -- 5 Diagnosis -- 6 Surgical Treatment -- 7 Orbitozygomatic Craniotomy Key Surgical Steps: [22, 23] -- 7.1 Positioning -- 7.2 Dissection -- 7.3 Craniotomy -- 7.4 Dural Opening and Cranial Approach -- 7.5 Reconstruction -- 8 Subtemporal Craniotomy Key Surgical Steps: [22, 23]. ; 8.1 Positioning.
• Titolo autorizzato: Anesthesia for Oncological Surgery
• ISBN: 3-031-50977-3
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910842296303321
• Lo trovi qui: Univ. Federico II